Detalhe da pesquisa
1.
The Splicing Efficiency of Activating HRAS Mutations Can Determine Costello Syndrome Phenotype and Frequency in Cancer.
PLoS Genet
; 12(5): e1006039, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27195699